Furthermore, we analyzed the coronavirus disease―COVID-19 signaling pathway through the KEGG online platform and speculated that the hypoglycemic effect of sitagliptin may be closely related to the ACE2/Ang-(1-7)/Mas receptor (MasR) axis (Figure S1). This evidence concerns the gene MAS1L and COVID-19.